Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria

• Austin G. Kulasekararaj,
• Anna-Elina Lehtinen,
• Cecily Forsyth,
• Shreyans Gandhi,
• Morag Griffin,
• Sixten Körper,
• Gabor Mikala,
• Petra Muus,
• Ulrik Overgaard,
• Christopher J. Patriquin,
• Humphrey Pullon,
• Yu-Min Shen,
• Ruth Spearing,
• Jeff Szer,
• Guillemette de la Borderie,
• Petra W. Duda,
• Ramin Farzaneh-Far,
• Sharan Ragunathan,
• Camil E. Sayegh,
• Douangsone D. Vadysirisack,
• Hubert Schrezenmeier

Affiliations

Austin G. Kulasekararaj

King’s College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, London, UK and King’s College London, London

Anna-Elina Lehtinen

Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki

Cecily Forsyth

Gosford Hospital, Gosford, NSW

Shreyans Gandhi

King’s College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, London, UK and King’s College London, London

Morag Griffin

St. James’s University Hospital, Leeds

Sixten Körper

University of Ulm, Institute of Transfusion Medicine, and Institute of Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm

Gabor Mikala

Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Budapest

Petra Muus

King’s College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, London, UK and King’s College London, London, UK; St. James’s University Hospital, Leeds

Ulrik Overgaard

University Hospital Copenhagen, Copenhagen, Denmark

Christopher J. Patriquin

University Health Network, Toronto, ON

Humphrey Pullon

Waikato Hospital, Hamilton

Yu-Min Shen

UT Southwestern Medical Center, Dallas, TX

Ruth Spearing

Christchurch Hospital, Christchurch

Jeff Szer

Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC

Guillemette de la Borderie

Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC

Petra W. Duda

UCB Pharma, Cambridge, MA

Ramin Farzaneh-Far

UCB Pharma, Cambridge, MA

Sharan Ragunathan

UCB Pharma, Cambridge, MA

Camil E. Sayegh

UCB Pharma, Cambridge, MA

Douangsone D. Vadysirisack

UCB Pharma, Cambridge, MA

Hubert Schrezenmeier

University of Ulm, Institute of Transfusion Medicine, and Institute of Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm